home / stock / wint / wint news

WINT News and Press, Windtree Therapeutics Inc. From 04/22/24

Stock Information
Company Name: Windtree Therapeutics Inc.
Stock Symbol: WINT
Market: OTC
Website: windtreetx.com
Menu
WINT WINT Quote WINT Short WINT News WINT Articles WINT Message Board
Get WINT Alerts

News, Short Squeeze, Breakout and More Instantly...
WINT - Lexicon Pharmaceuticals, Bio-Path Holdings, Protara Therapeutics among healthcare movers

2024-04-22 10:01:12 ET More on Health Care Select Sector SPDR XLV: Fundamentals Don't Support Overweighting Health Care XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Tech advances are catalyzing the Health Care sector with improved ...
WINT - US Companies Moving the Markets, Morning edition
Mon, Apr 22, 2024 as of 10.00 am ET

A look at the top 10 most actives in the United States Moolec Science SA (MLEC) rose 85.7% to $2.6 on volume of 50,077,650 shares SuperCom Ltd. (SPCB) rose 46.0% to $0.3212 on volume of 37,315,721 shares AGBA Group Holding Limited (AGBA) rose 35.2% to $1.69 on volume of 26,672,582 shares ...

WINT - WINT announced stock split 1-18

2024-04-22 09:02:03 ET Windtree Therapeutics Inc (WINT) announced stock split at a ratio of 1-for-18 on 2024-04-22 ... Full story available on KlickAnalytics.com

WINT - Windtree Therapeutics approves reverse stock split

2024-04-18 08:04:28 ET More on Windtree Therapeutics Seeking Alpha’s Quant Rating on Windtree Therapeutics Historical earnings data for Windtree Therapeutics Read the full article on Seeking Alpha For further details see: Windtree Therapeutics appr...
WINT - Windtree Therapeutics GAAP EPS of -$0.95

2024-04-17 13:55:10 ET More on Windtree Therapeutics Seeking Alpha’s Quant Rating on Windtree Therapeutics Historical earnings data for Windtree Therapeutics Financial information for Windtree Therapeutics Read the full article on Seeking Alpha ...

WINT - Windtree Therapeutics GAAP EPS of $1.04, revenue of $58.72M

2024-04-17 13:32:17 ET More on Windtree Therapeutics Seeking Alpha’s Quant Rating on Windtree Therapeutics Historical earnings data for Windtree Therapeutics Financial information for Windtree Therapeutics Read the full article on Seeking Alpha ...

WINT - Windtree Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Key Business Updates

WARRINGTON, Pa., April 17, 2024 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or “the Company”) (NasdaqCM: WINT), a biotechnology company focused on advancing early and late-stage innovative therapies for critical conditions, today reported financial resu...
WINT - Windtree to buy certain assets of Varian Biopharmaceuticals

2024-04-08 16:58:32 ET More on Windtree TherapeuticS Seeking Alpha’s Quant Rating on Windtree TherapeuticS Historical earnings data for Windtree TherapeuticS Financial information for Windtree TherapeuticS Read the full article on Seeking Alpha ...

WINT - Windtree Acquires Early-Stage, Novel Oncology Platform and Completes $1.5 Million Convertible Note Bridge Financing

WARRINGTON, Pa., April 08, 2024 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), today announced that on April 2, 2024 the Company entered into an asset purchase agreement with Varian Biopharmaceuticals, Inc. (“Vari...

WINT - Expected US Company Earnings on Monday, April 1st, 2024

GD Culture Group Limited (GDC) is expected to report for Q4 2023 Citizens Inc. Class A ($1.00 Par) (CIA) is expected to report for quarter end 2023-12-31 Escalade Incorporated (ESCA) is expected to report for Q4 2023 Lendway Inc. (LDWY) is expected to report for quarter end 2023-12-31...
Previous 10 Next 10